BioRem Inc. (BRM.V)
| Previous Close | 0.8400 |
| Open | 0.8500 |
| Bid | 0.8500 x 0 |
| Ask | 0.8900 x 0 |
| Day's Range | 0.8500 - 0.8500 |
| 52 Week Range | 0.6600 - 0.9900 |
| Volume | |
| Avg. Volume | 5,183 |
| Market Cap | 13.156M |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | 17.00 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Biorem Reports Third Quarter Results & Increases in Revenues and Earnings
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2022. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
- CNW Group
New growth initiatives drive BIOREM order backlog to record $44.5M
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totalling $7.1 million. The orders are for air emission abatement projects in North America and continue to increase BIOREM's order backlog to a record $44.5 million, its highest point since the Company was founded in 1990.
- CNW Group
Biorem Reports Second Quarter Results & Record Order Backlog
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2022. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
